ArticleOncotarget2018

TRKB tyrosine kinase receptor is a potential therapeutic target for poorly differentiated oral squamous cell carcinoma.

Kazumasa Moriwaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.